A new optimised intensity-modulated radiation therapy (IMRT) pioneered at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, has been shown to spare head and neck cancer patients’ adverse life-long side effects post treatment.
Read the full article from The Institute of Cancer Research here.